Company · CIK 1867096

# Xeris Biopharma Holdings, Inc.

| CIK | [1867096](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001867096) (SEC EDGAR) |
| --- | --- |
| Industry (SIC) | 2834 — Pharmaceutical Preparations |
| Business address | IL |
| Listed | XERS (Nasdaq) |
| First annual or quarterly report | 2021-11-10 |

## Offerings

 3 registrations

| Registration | Label and status | First filed | Last event | Filings |
| --- | --- | --- | --- | --- |
| 333-285597 | Shelf Effective | 2025-03-06 | 2025-05-13 | 2 |
| 333-262404 | Shelf Effective | 2022-01-28 | 2022-05-11 | 3 |
| 333-262403 | Shelf Effective | 2022-01-28 | 2022-02-07 | 2 |

## Filings

 8

| Filed | Filing | Registration | Accession |
| --- | --- | --- | --- |
| 2025-05-13 | [EFFECT](https://www.sec.gov/Archives/edgar/data/1867096/999999999525001553/9999999995-25-001553-index.htm) Declared effective | 333-285597 | 9999999995-25-001553 |
| 2025-03-06 | [S-3](https://www.sec.gov/Archives/edgar/data/1867096/000186709625000041/0001867096-25-000041-index.htm) Shelf registered | 333-285597 | 0001867096-25-000041 |
| 2022-05-11 | [424B5](https://www.sec.gov/Archives/edgar/data/1867096/000119312522147610/0001193125-22-147610-index.htm) Shelf takedown | 333-262404 | 0001193125-22-147610 |
| 2022-02-07 | [EFFECT](https://www.sec.gov/Archives/edgar/data/1867096/999999999522000356/9999999995-22-000356-index.htm) Declared effective | 333-262404 | 9999999995-22-000356 |
| 2022-02-07 | [EFFECT](https://www.sec.gov/Archives/edgar/data/1867096/999999999522000355/9999999995-22-000355-index.htm) Declared effective | 333-262403 | 9999999995-22-000355 |
| 2022-01-28 | [S-3](https://www.sec.gov/Archives/edgar/data/1867096/000162828022001449/0001628280-22-001449-index.htm) Shelf registered | 333-262404 | 0001628280-22-001449 |
| 2022-01-28 | [S-3](https://www.sec.gov/Archives/edgar/data/1867096/000162828022001447/0001628280-22-001447-index.htm) Shelf registered | 333-262403 | 0001628280-22-001447 |
| 2021-07-29 | [EFFECT](https://www.sec.gov/Archives/edgar/data/1867096/999999999521002977/9999999995-21-002977-index.htm) Declared effective | 333-257642 | 9999999995-21-002977 |

[All filings of this company](https://equitycapital.markets/filings?cik=1867096) · [CSV](https://equitycapital.markets/filings.csv?cik=1867096)

---
Source page: https://equitycapital.markets/company/1867096 · Data: U.S. SEC EDGAR · CC BY 4.0